CleanSlate
CleanSlate is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at CleanSlate.
CleanSlate is a company.
Key people at CleanSlate.
Key people at CleanSlate.
CleanSlate Centers is a national medical group specializing in outpatient treatment for opioid and alcohol use disorders, offering physician-led, evidence-based care including medication-assisted treatment (MAT) and behavioral health therapies.[2][1] Founded in 2009 and headquartered in Brentwood, Tennessee, it serves individuals and communities impacted by the opioid crisis and alcohol addiction, addressing the chronic disease of addiction through an integrated model that has treated over 30,000 patients.[1][2] The company operates 45 centers across eight states and the District of Columbia as of 2018, with rapid expansion including 22 more centers planned that year, supported by $34.52M in total funding, including a $25M Series D round led by HealthQuest Capital.[1][2]
Its growth momentum stems from the escalating demand for accessible, high-quality outpatient addiction services amid the opioid epidemic, positioning it as an industry leader in transforming healthcare delivery for behavioral health.[1][2]
CleanSlate Centers was founded in 2009 in response to the growing opioid epidemic, establishing a national footprint starting from Brentwood, Tennessee.[2] Key early backing came from investors like Apple Tree Partners, a venture capital firm focused on pharmaceuticals, biotech, medtech, and healthcare services, which invested in the outpatient addiction treatment provider specializing in MAT for opioid dependence.[4] By 2017-2018, Granite Growth Health Partners, a healthcare-focused growth equity firm founded in October 2017 by partners including Diane Daych, became a controlling investor after Daych's prior investments in CleanSlate at a previous venture firm; they co-invested in the pivotal $25M round led by HealthQuest Capital.[1]
Early traction built through a proven model of office-based treatment, expanding to treat over 30,000 patients with evidence-based medicine and opening new centers monthly, marking significant milestones in scaling against rising addiction rates.[1]
(Note: Search results distinguish CleanSlate Centers from unrelated entities like CleanSlate Technology Group, a cloud consulting firm.[3])
CleanSlate Centers rides the wave of the U.S. opioid crisis and rising awareness of addiction as a treatable chronic disease, capitalizing on market forces like policy shifts toward outpatient MAT and behavioral health integration.[1][2] Its timing aligns with healthcare's push for accessible, non-residential treatment amid surging demand—opioid overdoses and alcohol-related issues strained systems, creating opportunities for scalable models like CleanSlate's.[1] By expanding centers in high-need states, it influences the ecosystem through evidence-based care delivery, partnering with investors to strengthen health services infrastructure and set standards for addiction treatment amid evolving reimbursement and telehealth trends.[1][2]
CleanSlate Centers is poised for continued expansion, likely leveraging post-2018 momentum to surpass its 45-center base through further funding and partnerships, adapting to trends like telehealth integration and AI-driven behavioral health tools.[1][2] Evolving regulations favoring MAT and value-based care will shape its path, potentially amplifying influence as a leader in outpatient addiction services amid persistent public health needs. This positions it to deepen impact on healthier communities, echoing its founding mission to transform addiction care nationwide.[1]
